News

Hudson Institute’s reputation as a leader in inflammation research has been boosted by the appointment of two specialists in the field.…  Read more

Hudson Institute post-doctoral researcher Dr Shanti Gurung and her team are celebrating a double boost of funding for their work on endometriosis.…  Read more

Hudson Institute is a key player in an exciting new primary aldosteronism (PA) project investigating the causes of primary aldosteronism, a common and potentially preventable cause of cardiovascular disease.…  Read more

New ways to prevent and cure pelvic organ prolapse (POP) are a big step closer, thanks to major funding for pioneering research at Hudson Institute.…  Read more

Babies affected by Fetal Growth Restriction (FGR) have poor cardiorespiratory control; now Hudson Institute researchers have become the first to show persistent injury in the brainstem of growth restricted fetuses as the likely cause. …  Read more

Hudson Institute partner BiomeBank has secured a multimillion-dollar Federal Government grant that will turbocharge the development and production of microbiome-based therapeutics.…  Read more

A deadly form of children’s brain cancer that’s immune to chemotherapy is the target of new research at Hudson Institute, looking at the epigenome and immuno-therapies for answers.…  Read more

Every mother wants to have the healthiest child she can, and new research shows that the nutritional status of the mother during pregnancy can affect outcomes for the baby – with male and female offspring affected differently.…  Read more

Correct development of testes in a male foetus – and fertility later in life – depend on a crucial hormone being at just the right level.…  Read more

Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.…  Read more